trending Market Intelligence /marketintelligence/en/news-insights/trending/s0pgjp5h7b4wflrenfgzqg2 content esgSubNav
In This List

Natus board approves $30M share repurchase program

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Natus board approves $30M share repurchase program

The Natus Medical Inc. board authorized the repurchase of up to $30 million of the company's common shares.

The Pleasanton, Calif.-based healthcare distributor will use cash on hand, cash generated from operations, as well as existing credit facilities or other financing to fund the transaction.

As of Dec. 31, 2017, the company had cash and cash equivalents of approximately $89 million and availability under an existing line of credit of $70 million.

The share repurchase program is set to expire Feb. 26, 2019.